As we approach the end of the first quarter of 2020, investment fund managers and investors in non-traded or infrequently traded debt and equity investments have a fiduciary duty to report independent and credible fair value information to investors and stakeholders. This process is complicated by the rapidly changing global health situation due to the coronavirus (COVID-19). Given the volatility demonstrated in the public markets and the unknown ultimate global impact of COVID-19, using informed judgment to estimate the fair value of investments will require even more thought and analysis.
Please join us for a discussion on how best to reflect the impact of COVID-19 on estimating and reporting fair value for the March 31, 2020 quarter end.
Discussion topics include:
Srividya Gopal, Managing Director and Southeast Asia Leader
David Larsen, Managing Director, Portfolio Valuation, U.S.
Rishi Aswani, Managing Director, Portfolio Valuation, Mumbai
Bennett Cupit, Director, Portfolio Valuation, Hong Kong